CDK12-IN-3

CAS : 2220184-50-7

Ref. 3D-VND18450

Informations sur le produit

• Nom: CDK12-IN-3
• Marque: Biosynth
• Description: CDK12-IN-3 is a selective inhibitor targeting Cyclin-Dependent Kinase 12 (CDK12). It is synthesized as a small molecule compound designed for research and therapeutic exploration. The action of CDK12-IN-3 involves the inhibition of CDK12, a kinase crucial for regulating transcription elongation and mRNA processing, particularly in genes with large transcription units. By inhibiting CDK12, CDK12-IN-3 affects the transcriptional program responsible for DNA damage response and repair pathways.The applications of CDK12-IN-3 are primarily within cancer research, where it serves as a valuable tool to study the role of CDK12 in tumorigenesis. Given the involvement of CDK12 in maintaining genomic stability, its inhibition provides insights into vulnerabilities in cancer cells that can be exploited for therapeutic interventions. Research employing CDK12-IN-3 can lead to the development of novel strategies for targeting cancers with specific genetic backgrounds or resistance mechanisms. As a research compound, CDK12-IN-3 facilitates both basic science and translational studies aiming to improve our understanding of cancer biology and treatment options.

Propriétés chimiques

• Masse moléculaire: 470.5 g/mol
• Formule: C₂₃H₂₈F₂N₈O
• Degré de pureté: Min. 95%